Corrigendum to “Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan” [Journal of Neuroimmunology 385 (2023) 578241].

IF 2.9 4区医学 Q3 IMMUNOLOGY

Journal of neuroimmunology Pub Date : 2024-10-25 DOI:10.1016/j.jneuroim.2024.578465

Manato Yasuda , Akiyuki Uzawa , Satoshi Kuwabara , Shigeaki Suzuki , Hiroyuki Akamine , Yosuke Onishi , Yukiko Ozawa , Naoki Kawaguchi , Tomoya Kubota , Masanori P. Takahashi , Yasushi Suzuki , Genya Watanabe , Takashi Kimura , Takamichi Sugimoto , Makoto Samukawa , Naoya Minami , Masayuki Masuda , Shingo Konno , Yuriko Nagane , Kimiaki Utsugisawa

引用次数: 0

查看原文本刊更多论文

日本肌肉特异性激酶抗体阳性肌无力患者的临床特征和预后》[《神经免疫学杂志》385 (2023) 578241]更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of neuroimmunology 医学-免疫学

CiteScore

6.10

自引率

3.00%

发文量

154

审稿时长

37 days

期刊介绍： The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.